Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries.

Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries.. Arango, Celso; Buitelaar, Jan K.; Fegert, Jörg M.; Olivier, Valérie; Pénélaud, Pierre-François; Marx, Ute; Chimits, Damien; Falissard, Bruno. The lancet. Psychiatry. 2022; 9: p.113-124. doi:10.1016/S2215-0366(21)00390-4
Article